Perbedaan UBC Medical Indonesia Tbk. dan Trimegah Karya Pratama Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb), sedangkan Trimegah Karya Pratama Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 292,02 M, volume 24 jam 23,22 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 2,2× kapitalisasi pasar Trimegah Karya Pratama Tbk., dan Trimegah Karya Pratama Tbk. lebih aktif diperdagangkan (23,22 jt vs 843 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | UVCR | |
|---|---|---|
Kapitalisasi Pasar | 635,95 M | 292,02 M |
Volume | 843 rb | 23,22 jt |
Lot | 8,43 rb | 232,24 rb |
Perputaran | 137,6 jt | 3,36 M |
Harga Rata-rata | 163,22 | 144,89 |
Nilai Transaksi | 137,6 jt | 3,36 M |
Harga Ekuilibrium Indikatif | 165 | 146 |
Volume Ekuilibrium Indikatif | 246 | 410 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Selengkapnya di halaman UVCR →